Want to join the conversation?
$MNK's 2Q16 net sales rose 2.1% versus 2Q15, mainly driven by growth in Specialty Brands due to inclusion of Inomax and Therakos net sales. Specialty Generics net sales fell 27.1% due to dip in net sales of some products. Nuclear Imaging net sales fell 6.7% due to lower net sales of generators and an unfavorable exchange rate impact.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.